Ownership: Thomas Massung, Innate Immunotherapeutics

Thomas Massung is an owner of Innate Immunotherapeutics

Title Investor
Is Current yes
Percent Stake 1%
Shares 2.8 Million
Updated over 7 years ago

Source Links